Skip to content

Mechanical Insufflation-Exsufflation in Preventing Post Extubation Respiratory Failure in Patient With Critical Care Neuromyopathy

Contribution of Mechanical Insufflation-Exsufflation in Preventing Respiratory Failure Post Extubation in Patient With Critical Care Neuromyopathy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01931228
Acronym
NEUROMIE
Enrollment
123
Registered
2013-08-29
Start date
2012-05-03
Completion date
2016-05-31
Last updated
2018-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Insufficiency, Respiratory Failure

Keywords

Intensive care unit, acute respiratory insufficiency, Respiratory failure, Mechanical Insufflation-Exsufflation

Brief summary

Respiratory failure after extubation is a relevant consequence of poor airway clearance due to respiratory muscle weakness and respiratory failure after extubation and reintubation is associated with increased morbidity and mortality. the study will evaluate the contribution of Mechanical Insufflation-Exsufflation (MI-E) in Preventing Respiratory Failure After Extubation as compared manually assisted coughing

Detailed description

Critical Care Neuromyopathy (CCN) occur in 25% of patient in Intensive Care Unit (ICU). Respiratory failure after extubation is a relevant consequences of poor airway clearance due to respiratory muscle weakness. Respiratory failure is a major cause for reintubation which increase severity of illness, this is an independent risk factor for nosocomial pneumonia, increased hospital stay and mortality. Currently, respiratory physiotherapy includes, manual expiration assist often associated with nasotracheal aspiration. Despite of this care, respiratory failure occur in 30% of patients within 48 after planned extubation. MI-E has been evaluated for neuromuscular disease patient, and increase peak cough flow and the airway clearance. So the beneficials effects of MI-E should be confirmed in a trial in this specific population. We planned to conduct a study evaluating the efficacy of MI-E in the prevention of extubation failure and mortality in these patients. If no signs of respiratory failure appeared after 120 min of a spontaneous breathing trial, patients will be extubated and randomly allocated after extubation to MI-E group or control group. The clinical follow-up will be as follow: the incidence of extubation failure, the reintubation, the ICU or 28-day survival,90-day survival, ICU length of stay.

Interventions

PROCEDUREMI-E plus manually assisted coughing

MI-E plus manually assisted coughing twice a day for 48h after extubation. After this period and before discharge of the icu or day28 maximum, patients received only one daily session.

PROCEDUREmanually assisted coughing

Manually assisted coughing twice a day for 48h after extubation. After this period and before discharge of the icu or day28 maximum, patients received only one daily session.

Sponsors

University Hospital, Bordeaux
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female patient aged ≥ 18 years. * Patient admitted in participant ICU. * Patient intubated for 48 hours at least. * Patient presenting an ICU acquired neuromuscular disorders.

Exclusion criteria

* Respiratory or haemodynamic instability. * Patient having a contraindication to use face mask (Recent facial surgery, severe craniofacial trauma,…) gastroesophageal surgery. * Severe ventricular rhythm disorders. * Patient with tracheotomy. * Uncontrollable vomiting. * Severe sepsis. * Upper airway disorders. * Upper gastrointestinal bleeding. * Any decision to limit therapeutic effort in the ICU. * Patient with limit therapeutic effort in the ICU with unsuccessful spontaneous respiratory trial.

Design outcomes

Primary

MeasureTime frame
Incidence of respiratory failure after extubation48h post extubation (48h after inclusion)

Secondary

MeasureTime frame
the incidence of reintubationEnd of intensive care or day 28 after inclusion
the average time of hospitalization in the intensive care unitEnd of intensive care or day 28 after inclusion
the incidence of nasotracheal suctionEnd of intensive care or day 28 after inclusion
the increase in peak cough flowEnd of intensive care or day 28 after inclusion
the ICU mortality or 28-day survival28 days after inclusion
90 days survival90 days after inclusion
the number of additional physiotherapy sessionsEnd of intensive care or day 28 after inclusion

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026